Laman UtamaME • NASDAQ
add
23andMe Holding Co.
$3.11
Selepas Waktu Dagangan:(3.54%)+0.11
$3.22
Tutup: 22 Nov, 6:26:25 PTG GMT-5 · USD · NASDAQ · Penafian
Tutup sebelumnya
$3.23
Julat hari
$2.99 - $3.21
Julat tahun
$2.66 - $20.20
Permodalan pasaran
74.94J USD
Bilangan Purata
404.88K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Sep 2024info | Perubahan T/T |
---|---|---|
Hasil | 44.07J | -11.86% |
Perbelanjaan pengendalian | 81.33J | -17.18% |
Pendapatan bersih | -59.10J | 21.48% |
Margin untung bersih | -134.11 | 10.91% |
Pendapatan bagi setiap syer | — | — |
EBITDA | -54.96J | 21.06% |
Kadar cukai berkesan | 0.07% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Sep 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 126.60J | -50.62% |
Jumlah aset | 318.94J | -60.19% |
Jumlah liabiliti | 217.01J | 23.31% |
Jumlah ekuiti | 101.93J | — |
Syer tertunggak | 26.12J | — |
Harga kepada buku | 0.82 | — |
Pulangan pada aset | -42.89% | — |
Pulangan pada modal | -75.30% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Sep 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -59.10J | 21.48% |
Tunai daripada operasi | -40.93J | 28.34% |
Tunai daripada pelaburan | -2.70J | 2.63% |
Tunai daripada pembiayaan | 260.00K | -83.68% |
Perubahan bersih dalam tunai | -43.37J | 25.18% |
Aliran tunai bebas | -12.82J | 59.90% |
Perihal
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Diasaskan
Apr 2006
Tapak web
Pekerja
571